TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE – Trademark Portfolio
Entity Type: 17
TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include PASQUE and FLOWER OF THE DESERT.
Showing of trademarks Trademarks
Trademark Classifications
TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE have?
TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE file in?
TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE files trademarks across 1 Nice Classification class. The most active classes are Class 31 (Natural Agricultural Products). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE's most well-known trademarks?
TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE's registered trademark portfolio includes well-known marks such as PASQUE and FLOWER OF THE DESERT. These are among 2 currently registered trademarks in the portfolio.
What is TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE's trademark registration success rate?
TRUSTEES OF THE JOSEPHINE PASQUINELLI SURVIVOR'S TRUST, THE has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.